T1	Entity 628 645	European ancestry
T2	SNP 1613 1622	rs2588809
T4	Entity 1702 1706	TSMC
R2	Risk_Factor Arg1:T2 Arg2:T4	
T3	Association 1721 1732	association
E1	Association:T3 snp_int:T2 bc:T7
T6	Level 1737 1748	significant
R3	Level_marker Arg1:E1 Arg2:T6	
A1	Level E1 High
T7	Cancer 1752 1757	ER(+)
A2	Cancer_Type T7 Horm+ve_other
T8	Entity 1752 1754	ER
T9	Effect_Type 1755 1756	+
T10	Entity 920 948	total somatic mutation count
T11	Entity 950 954	TSMC
R4	Equiv Arg1:T10 Arg2:T11	
T12	Level 1737 1748;1809 1812	significant not
E2	Association:T3 bc:T13 snp_int:T17
A3	Level E2 Low
R6	Level_marker Arg1:E2 Arg2:T12	
T13	Cancer 1819 1824	ER(-)
A4	Cancer_Type T13 ER-
T14	Entity 1819 1821	ER
T15	Neg 1822 1823	-
T16	Entity 1842 1847;1857 1860	ER(-) PRS
T17	SNP 1613 1622	rs2588809
R7	Risk_Factor Arg1:T17 Arg2:T4	
T18	Entity 1776 1781;1791 1794	ER(+) PRS
R8	Risk_Factor Arg1:T2 Arg2:T18	
R9	Risk_Factor Arg1:T17 Arg2:T16	
T19	Entity 1054 1074	polygenic risk score
T20	Entity 1076 1079	PRS
R10	Equiv Arg1:T19 Arg2:T20	
T21	Entity 1146 1164	oestrogen-receptor
T22	Entity 1166 1168	ER
R11	Equiv Arg1:T21 Arg2:T22	
T23	Entity 1174 1195	progesterone-receptor
T24	Entity 1197 1199	PR
R12	Equiv Arg1:T23 Arg2:T24	
T25	SNP 1387 1396	rs2588809
T26	Entity 1409 1415	RAD51B
R13	SNP_coupled_gene Arg1:T25 Arg2:T26	
T28	Association 1319 1330	association
E3	Association:T28 snp_int:T25 bc:T29 bc2:T30
T27	Entity 1420 1424	TSMC
R14	Risk_Factor Arg1:T25 Arg2:T27	
T29	Cancer 1469 1474;1485 1492	ER(+) tumours
A5	Cancer_Type T29 ER+
T30	Cancer 1479 1492	ER(-) tumours
A6	Cancer_Type T30 ER-
T31	Entity 1469 1471	ER
T32	Effect_Type 1472 1473	+
T33	Entity 1479 1481	ER
T34	Neg 1482 1483	-
T35	Organic_inorganic_molecules_affected 1319 1330	association
E4	Organic_inorganic_molecules_affected:T35 Agent:T25 Theme:T31
E5	Organic_inorganic_molecules_affected:T35 Agent:T25 Theme:T33
A7	Effect_Type E4 Increase
R15	Effect_type_marker Arg1:E4 Arg2:T32	
R16	Negation_marker Arg1:E5 Arg2:T34	
T5	Entity 1566 1569	PRS
R17	Risk_Factor Arg1:T2 Arg2:T5	
R18	Risk_Factor Arg1:T17 Arg2:T5	
T36	Spec 1961 1973	if confirmed
T37	Association 1894 1905	association
E6	Association:T37 
R19	Speculation_marker Arg1:E6 Arg2:T36	
R20	Equiv Arg1:E1 Arg2:E6	
R21	Equiv Arg1:E2 Arg2:E6	
T38	Organic_inorganic_molecules_affected 1721 1732	association
E7	Organic_inorganic_molecules_affected:T38 Theme:T14 Agent:T2
E8	Organic_inorganic_molecules_affected:T38 Theme:T8 Agent:T17
R22	Effect_type_marker Arg1:E8 Arg2:T9	
A8	Effect_Type E8 Increase
R23	Negation_marker Arg1:E7 Arg2:T15	
T39	Entity 1121 1137	age at diagnosis
T40	Entity 1139 1144;1208 1224	stage of breast cancer
T41	Entity 1267 1269;1277 1283	ER status
T42	Entity 1274 1283	PR status
R24	Risk_Factor Arg1:T25 Arg2:T42	
R25	Risk_Factor Arg1:T25 Arg2:T41	
R26	Risk_Factor Arg1:T25 Arg2:T39	
R27	Risk_Factor Arg1:T25 Arg2:T40	
T43	Entity 1372 1383	risk allele
R28	SNP_allele Arg1:T25 Arg2:T43	
R1	Population_assignment Arg1:T25 Arg2:T1	
R5	Equiv Arg1:T17 Arg2:T25	
R29	Equiv Arg1:T2 Arg2:T25	
